OptimizeRx (OPRX)
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences wi...
- Open
- 8.420
- High
- 8.860
- Low
- 8.295
- Prev. Close
- 8.350
- Volume
- 196.47K
- Turnover
- 1.66M
- Avg Price
- 8.466
- Bid/Ask Ratio
- --
- Amplitude
- 6.77%
- 52wk High
- 22.250
- Volume Ratio
- 1.03
- Turnover Ratio
- 1.36%
- 52wk Low
- 4.540
- Float Mkt Cap
- 121.47M
- Market CapUSD
- 158.03M
- P/ETTM
- 34.35
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- 0.244
- EPSDynamic
- -0.127
- EPSStatic
- --
- BVPS
- 6.96
- P/B
- 1.21
- Circulating Supply
- 14.48M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 18.84M
- Min lot size
- 1
- Currency
- USD
OptimizeRx Analyst Rating
View moreForecast & Rating
Sep 29, 2026Price forecast
$12.6050.18%
Forecast & RatingStrong buy
6analysts
- Strong buy83.33%
- Buy16.67%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- TradingView · 2 days ago, 03:45 PM
B. Riley Securities maintains Buy rating on OptimizeRx, $11 price target
- PUBT · Sep 22 at 12:08 PM
OptimizeRx integrates with Trade Desk OpenPath to offer authenticated EHR ad inventory
- PUBT · Sep 14 at 12:06 PM
OptimizeRx expands Natural Language Audience Builder to add DTC targeting workflow
- PUBT · Sep 8 at 11:32 AM
OptimizeRx management participates in Lake Street Capital Best Ideas Growth Conference
- PUBT · Sep 2 at 11:31 AM
OptimizeRx appoints former J&J commercial data science chief Troy Sarich as adviser
